These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 3021967)

  • 41. Epidemiological, clinical and therapeutic features of pediatric kala-azar.
    Rahim KM; Ashkan MM
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):626-30. PubMed ID: 17882998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathological study of clinically undiagnosed cases of kala-azar with special reference to grading of parasites.
    Mukherjee C; Mitra PK; Dasgupta A; Ghosh RN
    J Indian Med Assoc; 1995 Mar; 93(3):87-9. PubMed ID: 8522820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis.
    Singh R; Kumar D; Ramesh V; Negi NS; Singh S; Salotra P
    J Infect Dis; 2006 Aug; 194(3):302-6. PubMed ID: 16826477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complications of kala azar and its treatment in Kenya.
    Chunge CN; Gachihi G; Chulay JD; Spencer HC
    East Afr Med J; 1984 Feb; 61(2):120-7. PubMed ID: 6088210
    [No Abstract]   [Full Text] [Related]  

  • 45. [Kala-azar--an endemic disease close to Switzerland. Apropos of 2 cases in children observed in Geneva].
    Thélin O
    Rev Med Suisse Romande; 1985 Apr; 105(4):363-8. PubMed ID: 2990003
    [No Abstract]   [Full Text] [Related]  

  • 46. [Kala-azar; clinical and physiopathological study a propos of a new case studied in Switzerland].
    Pugin P; Miescher PA
    Schweiz Med Wochenschr; 1979 Feb; 109(8):265-9. PubMed ID: 219473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transfusion transmitted leishmaniasis: a case report and review of literature.
    Dey A; Singh S
    Indian J Med Microbiol; 2006 Jul; 24(3):165-70. PubMed ID: 16912434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative studies on IFAT, ELISA & DAT for serodiagnosis of visceral leishmaniasis in Bangladesh.
    Alam MJ; Rahman KM; Asna SM; Muazzam N; Ahmed I; Chowdhury MZ
    Bangladesh Med Res Counc Bull; 1996 Apr; 22(1):27-32. PubMed ID: 9037842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent observations on the epidemiology of kala-azar in the eastern and central states of the Sudan.
    el-Hassan AM; Zijlstra EE; Ismael A; Ghalib HW
    Trop Geogr Med; 1995; 47(4):151-6. PubMed ID: 8560585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Imported visceral leishmaniasis (kala azar) in a German infant].
    Emeis M; Liesenfeld O; Henze G; Meredith S; Schoone G; Stück B
    Klin Padiatr; 1995; 207(6):347-9. PubMed ID: 8569138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-kala-azar dermal leishmaniasis occurring long after cure of visceral leishmaniasis in Kenya.
    Rashid JR; Chunge CN; Oster CN; Wasunna KM; Muigai R; Gachihi GS
    East Afr Med J; 1986 May; 63(5):365-71. PubMed ID: 3017678
    [No Abstract]   [Full Text] [Related]  

  • 52. Leishmanin skin test in clinical and subclinical kala-azar cases.
    Saran R; Gupta AK; Sharma MC
    J Commun Dis; 1991 Jun; 23(2):135-7. PubMed ID: 1940219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and laboratory study of kala-azar in children in Nepal.
    Singh K; Singh R; Parija SC; Faridi MM; Bhatta N
    J Trop Pediatr; 1999 Apr; 45(2):95-7. PubMed ID: 10341503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar.
    Pampiglione S; Manson-Bahr PE; La Placa M; Borgatti MA; Musumeci S
    Trans R Soc Trop Med Hyg; 1975; 69(1):60-8. PubMed ID: 1145719
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Visceral leishmaniasis (kala-azar) in acquired immunodeficiency syndrome (AIDS)].
    Just G; Simader R; Helm EB; Stille W; Falk S; Stutte HJ; Hübner K
    Dtsch Med Wochenschr; 1988 Dec; 113(49):1920-2. PubMed ID: 2848675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Malda district (West Bengal).
    Gupta S; Srivastava JK; Ray S; Chandra R; Srivastava VK; Katiyar JC
    Indian J Med Res; 1993 Nov; 97():242-6. PubMed ID: 8144206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Survey on a new case of visceral leishmaniasis in Shanxi Province].
    Cai HX; Zuo SJ; Xu WX; Wu WP; Li J; Xu KJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Jun; 30(3):188-90. PubMed ID: 23072132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens.
    Zijlstra EE; Siddig Ali M; el-Hassan AM; Hofland HW; el-Toum I; Satti M; Ghalib HW
    Trans R Soc Trop Med Hyg; 1993; 87(3):307-9. PubMed ID: 8236402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology of kala-azar in rural Bihar (India) using village as a component unit of study.
    Dhiman RC; Sen AB
    Indian J Med Res; 1991 May; 93():155-60. PubMed ID: 1937592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of age and sex on incidence of kala-azar.
    Sharma MC; Gupta AK; Saran R; Sinha SP
    J Commun Dis; 1990 Dec; 22(4):277-8. PubMed ID: 2098434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.